James Pirkle to Substrate Specificity
This is a "connection" page, showing publications James Pirkle has written about Substrate Specificity.
Connection Strength
0.117
-
Wang D, Baudys J, Ye Y, Rees JC, Barr JR, Pirkle JL, Kalb SR. Improved detection of botulinum neurotoxin serotype A by Endopep-MS through peptide substrate modification. Anal Biochem. 2013 Jan 15; 432(2):115-23.
Score: 0.026
-
Kalb SR, Baudys J, Webb RP, Wright P, Smith TJ, Smith LA, Fernández R, Raphael BH, Maslanka SE, Pirkle JL, Barr JR. Discovery of a novel enzymatic cleavage site for botulinum neurotoxin F5. FEBS Lett. 2012 Jan 20; 586(2):109-15.
Score: 0.025
-
Parks BA, Shearer JD, Baudys J, Kalb SR, Sanford DC, Pirkle JL, Barr JR. Quantification of botulinum neurotoxin serotypes A and B from serum using mass spectrometry. Anal Chem. 2011 Dec 01; 83(23):9047-53.
Score: 0.025
-
Kalb SR, Baudys J, Egan C, Smith TJ, Smith LA, Pirkle JL, Barr JR. Different substrate recognition requirements for cleavage of synaptobrevin-2 by Clostridium baratii and Clostridium botulinum type F neurotoxins. Appl Environ Microbiol. 2011 Feb; 77(4):1301-8.
Score: 0.023
-
Boyer AE, Quinn CP, Woolfitt AR, Pirkle JL, McWilliams LG, Stamey KL, Bagarozzi DA, Hart JC, Barr JR. Detection and quantification of anthrax lethal factor in serum by mass spectrometry. Anal Chem. 2007 Nov 15; 79(22):8463-70.
Score: 0.019